NeuroSense Therapeutics Ltd. NRSN
Full chart
Set alert
1.69 USD -0.07 (-3.98%)
Regular-session close
1.71 +0.02 +1.18%
After hours · Nov 13, 4:00 PM ET
1.60 Day range 1.78
1.10 52-week range 25.40
- YTD
- -89.01%
- 1 year
- -90.80%
1Y chart
Chart tools· Candles· 4 studies
Signals (43)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| RSI: Oversold | Aug 10, 2026 | 3 months ago |
| RSI: Oversold | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 5 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
Newest 20 of 43.
Compare NRSN
Chart and line up NRSN against other symbols or a saved comparison set.
- NRSN NeuroSense Therapeutics Ltd.
1.69
-0.07 -3.98%
- SPY State Street SPDR S&P 500 ETF Trust
754.37
-2.75 -0.36%
- QQQ Invesco QQQ Trust
679.89
-8.28 -1.20%
Sign in to keep these symbols in a saved comparison set.
| Metric | NRSN | SPY | QQQ |
|---|---|---|---|
| Last price | 1.69 | 754.37 | 679.89 |
| Change | -0.07 | -2.75 | -8.28 |
| Change % | -3.98% | -0.363219% | -1.20% |
| Open | 1.77 | 760.07 | 688.51 |
| Day high | 1.78 | 760.12 | 688.75 |
| Day low | 1.60 | 747.89 | 671.71 |
| Previous close | 1.76 | 757.12 | 688.17 |
| Volume | 18.16K | 37.23M | 42.10M |
| Average volume | 32.59K | 43.10M | 38.73M |
| Market cap | 3.21M | 802.99B | 472.40B |
| P/E ratio | 0.00 | 24.00 | 28.00 |
| Earnings per share | -47.10 | 31.43 | 24.28 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 25.40 | 781.62 | 762.86 |
| 52-week low | 1.10 | 629.28 | 555.60 |
| 1-week return | +0.595238% | +2.59% | +3.63% |
| 1-month return | -51.58% | -3.04% | -8.56% |
| 3-month return | -80.93% | -3.02% | -7.13% |
| 6-month return | -89.86% | +1.62% | -4.87% |
| Year-to-date return | -89.01% | +10.62% | +10.68% |
| 1-year return | -90.80% | +12.25% | +11.75% |
| 2-year return | -93.65% | +26.32% | +32.73% |
| 50-day moving average | 4.14 | 764.43 | 717.87 |
| 200-day moving average | 11.99 | 731.92 | 682.24 |
| Target price | 7.50 | — | — |
| Beta | 1.57 | 1.00 | 1.24 |
| Short ratio | 2.01 | — | — |
| Institutional ownership | 0.974% | — | — |
